KVUE:NYSE
Kenvue Inc
$17.68
arrow_upward
+4.74%(+0.80) 1D
Jun 5, 3:23:07 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KVUE...
Open
$17.01
High
$17.77
Low
$16.95
Mkt. cap
33.94B
Avg. vol.
20.72M
Volume
18.56M
Dividend
4.69%
Quarterly dividend
$0.21
Ex-dividend date
May 13, 2026
P/E ratio
20.97
52-wk high
$22.87
52-wk low
$14.02
EPS
$0.84
Beta
0.54
Shares outstanding
1.92B
No. of employees
22K
Open
$17.01
High
$17.77
Low
$16.95
Mkt. cap
33.94B
Avg. vol.
20.72M
Volume
18.56M
Dividend
4.69%
Quarterly dividend
$0.21
Ex-dividend date
May 13, 2026
P/E ratio
20.97
52-wk high
$22.87
52-wk low
$14.02
EPS
$0.84
Beta
0.54
Shares outstanding
1.92B
No. of employees
22K
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to KVUE in the past 3 months
Hold
Buy
0
Hold
6
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for KVUE in the last 3 months.
Highest
Current $17.68
$21.00 (+18.78%)
Average
$18.80 (+6.33%)
Lowest
$18.00 (+1.81%)
News stories
From sources across the web
TipRanks
·
18 minutes ago
Kenvue, Inc. Stock Jumps on Takeover Optimism
Simply Wall Street
·
3 hours ago
Is It Time To Reassess Kenvue (KVUE) After Recent Share Price Weakness?
Yahoo Finance
·
5 hours ago
Jim Cramer Says He Likes “Kimberly-Clark Because It’s Merging With Kenvue”
Profile
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
About Kenvue Inc
CEO-
Employees21.9K
FoundedFeb 23, 2022
HeadquartersSummit, New Jersey, United States
SectorPersonal care products
Websitekenvue.com
AI content may include mistakes. Learn more